Glen Eagle Advisors’s Bausch Health BHC Stock Holding History

Glen Eagle Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-141	Closed	-$885	–	1092
2022 Q4	$885	Hold	141	–	–	﹤0.01%	1032
2022 Q3	$971	Buy	+141	New	+$979	﹤0.01%	979
2020 Q3	–	Sell	-225	Closed	-$4.12K	–	918
2020 Q2	$4.12K	Buy	+225	New	+$3.96K	﹤0.01%	695
2019 Q4	–	Sell	-200	Closed	-$4.37K	–	903
2019 Q3	$4.37K	Hold	200	–	–	﹤0.01%	652
2019 Q2	$5.06K	Hold	200	–	–	﹤0.01%	622
2019 Q1	$4.94K	Hold	200	–	–	﹤0.01%	586
2018 Q4	$3.7K	Hold	200	–	–	﹤0.01%	586
2018 Q3	$5.13K	Buy	+200	New	+$4.58K	﹤0.01%	557

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Glen Eagle Advisors's BHC Position: Q1 2023 in Review

Glen Eagle Advisors sold out of Bausch Health (BHC) in Q1 2023, closing a stake of 141 shares — an estimated $885 sold.

Glen Eagle Advisors first reported a position in BHC in Q3 2018 and held it in 8 quarters. The position peaked at $5.13K in Q3 2018. 235 funds tracked by Wall St. Rank hold BHC as of Q1 2023.

Glen Eagle Advisors reported no remaining Bausch Health position as of Q1 2023 after selling out during the quarter.
Glen Eagle Advisors sold 141 Bausch Health shares in Q1 2023, an estimated $885.
Glen Eagle Advisors first reported a position in Bausch Health in Q3 2018 and held it in 8 quarters.
Glen Eagle Advisors's Bausch Health position peaked at $5.13K in Q3 2018.
235 funds tracked by Wall St. Rank held Bausch Health as of Q1 2023.

Based on Glen Eagle Advisors's 13F filing for Q1 2023, filed 13 Aug 2024.